Pyxis Oncology stockholders elect four directors, ratify Ernst & Young as auditor

Pyxis Oncology, Inc.

Dr. Santhosh Palani elected Class I director with 28,241,400 for, 93,674 withheld.
Class III directors elected: John Flavin (21,045,395 for), Lara Sullivan (24,369,861), Jakob Dupont (28,220,452).
Ratification of Ernst & Young as FY2024 auditor passed with 42,153,375 for, 151,087 against, 31,729 abstain.
Quorum of 42,336,191 shares present from 58,876,390 outstanding as of record date April 18, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.